Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of XVIPF will - over the next 2 Weeks and hit - by . In that time frame, XVIPF's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
XVIPF shares rose +1.26% in Monday, February 9, 2026's trading session, rising from a previous close of $23.52 to move at $23.52. The stock demonstrated notable intraday movement (see XVIPF's key stats for a full breakdown), fluctuating between $23.52 and $23.52, a 0 trading range. While recent weeks have seen some volatility, XVIPF has managed to secure a +13.62% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 519 shares changing hands, 269 more than the previous session. This amounted to $12.21K in total market activity.
Will XVIPF Continue Its Trend?
According to analyst ratings and projections for XVIPF, Xvivo Perfusion AB (publ) shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for XVIPF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the XVIPF stock forecast, now is not the best time to buy XVIPF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on XVIPF covering social and institutional perspectives.
XVIPF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into XVIPF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.83% to 63.57%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 59.01%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 49.57%, maintains a neutral outlook for the long term. Insights into XVIPF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

